SQZ Biotechnologies Company
SQZB
$0.028
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -40.96% | 5.18% | -30.56% | 40.17% | -1.83% |
| Total Depreciation and Amortization | 23.23% | -26.51% | -10.05% | 19.01% | 6.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 566.70% | 50.36% | -60.58% | -25.83% | 2.99% |
| Change in Net Operating Assets | 65.10% | 81.81% | 20.51% | -177.08% | -37.95% |
| Cash from Operations | 4.83% | 35.76% | -14.51% | 5.11% | -6.85% |
| Capital Expenditure | 100.00% | 27.69% | 35.64% | 10.62% | -41.25% |
| Sale of Property, Plant, and Equipment | -90.32% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -86.11% | 266.15% | 35.64% | 10.62% | -41.25% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -50.60% | -79.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -50.60% | -79.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.25% | 36.39% | -16.11% | 3.71% | -22.87% |